Establishing a framework for best practices for quality assurance and quality control in untargeted metabolomics
-
Published:2024-02-12
Issue:2
Volume:20
Page:
-
ISSN:1573-3890
-
Container-title:Metabolomics
-
language:en
-
Short-container-title:Metabolomics
Author:
Mosley Jonathan D.ORCID, Schock Tracey B., Beecher Chris W., Dunn Warwick B., Kuligowski JuliaORCID, Lewis Matthew R., Theodoridis Georgios, Ulmer Holland Candice Z., Vuckovic DajanaORCID, Wilson Ian D., Zanetti Krista A.ORCID
Abstract
Abstract
Background
Quality assurance (QA) and quality control (QC) practices are key tenets that facilitate study and data quality across all applications of untargeted metabolomics. These important practices will strengthen this field and accelerate its success. The Best Practices Working Group (WG) within the Metabolomics Quality Assurance and Quality Control Consortium (mQACC) focuses on community use of QA/QC practices and protocols and aims to identify, catalogue, harmonize, and disseminate current best practices in untargeted metabolomics through community-driven activities.
Aim of review
A present goal of the Best Practices WG is to develop a working strategy, or roadmap, that guides the actions of practitioners and progress in the field. The framework in which mQACC operates promotes the harmonization and dissemination of current best QA/QC practice guidance and encourages widespread adoption of these essential QA/QC activities for liquid chromatography-mass spectrometry.
Key scientific concepts of review
Community engagement and QA/QC information gathering activities have been occurring through conference workshops, virtual and in-person interactive forum discussions, and community surveys. Seven principal QC stages prioritized by internal discussions of the Best Practices WG have received participant input, feedback and discussion. We outline these stages, each involving a multitude of activities, as the framework for identifying QA/QC best practices. The ultimate planned product of these endeavors is a “living guidance” document of current QA/QC best practices for untargeted metabolomics that will grow and change with the evolution of the field.
Funder
Carlos III Health Institute Fonds de Recherche du Quebec - Sante
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Alarcon-Barrera, J. C., Kostidis, S., Ondo-Mendez, A., & Giera, M. (2022). Recent advances in metabolomics analysis for early drug development. Drug Discov Today, 27, 1763–1773. 2. Beger, R. D., Dunn, W. B., Bandukwala, A., Bethan, B., Broadhurst, D., Clish, C. B., Dasari, S., Derr, L., Evans, A., Fischer, S., Flynn, T., Hartung, T., Herrington, D., Higashi, R., Hsu, P. C., Jones, C., Kachman, M., Karuso, H., Kruppa, G., Lippa, K., Maruvada, P., Mosley, J., Ntai, I., O’Donovan, C., Playdon, M., Raftery, D., Shaughnessy, D., Souza, A., Spaeder, T., Spalholz, B., Tayyari, F., Ubhi, B., Verma, M., Walk, T., Wilson, I., Witkin, K., Bearden, D. W., & Zanetti, K. A. (2019). Towards quality assurance and quality control in untargeted metabolomics studies. Metabolomics, 15, 4. 3. Broadhurst, D., Goodacre, R., Reinke, S. N., Kuligowski, J., Wilson, I. D., Lewis, M. R., & Dunn, W. B. (2018). Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics, 14, 72. 4. Broeckling, C. D., Beger, R., Cheng, L. L., Cumeras, R., Cuthbertson, D., Dasari, S., Davis, W. C., Dunn, W. B., Evans, A., Fernández-Ochoa, A., Gika, H., Goodacre, R., Goodman, K. D., Gouveia, G. J., Hsu, P. C., Kirwan, J. A., Kodra, D., Kuligowski, J., Lan, R. S., Monge, M.E., Moussa, L.W., Nair, S., Reisdorph, N., Sherrod, S.D., Ulmer, C.Z., Vuckovic, D., Yu, L.R., Zhang, B., Theodoridis, G. & Mosley, J. D. (2023). Current practices in LC-MS untargeted metabolomics: A scoping review on the use of pooled quality control samples. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.3c02924 5. Clinical and Laboratory Standards Institute (2021). Dried blood spot specimen collection for newborn screening. (CLSI standard NBS01). Retrived from https://clsi.org/standards/products/newborn-screening/documents/nbs01/
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|